3M, in a statement, said the verdict “demonstrates once again that the CAEv2 product was effective and safe to use.”
“Today’s result, along with previous outcomes, affirms our confidence in our case and shows that plaintiffs face significant challenges—not just here but in all the trials in this litigation—as each case must be proven on its own facts. We look forward to defending ourselves at all ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
